Influenza vaccination and reduction in risk of ischemic heart disease among chronic obstructive pulmonary elderly

Computer Methods and Programs in Biomedicine

Volumn 111, Issue 2, 2013, Pages 507-511

  Huang, Chen Ling ^a,b   Nguyen, Phung Anh ^c,d   Kuo, Pih lian ^c   Iqbal, Usman ^c   Hsu, Yi Hsin Elsa ^c   Jian, Wen Shan ^c  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cohort research database; COPD (chronic obstructive pulmonary disease); IHD (ischemic heart disease); Influenza vaccine; Vaccination

Indexed keywords

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; INFLUENZA VACCINES; ISCHEMIC HEART DISEASE; RESEARCH DATABASE; VACCINATION;

CARDIOLOGY; HEALTH INSURANCE; VACCINES;

PULMONARY DISEASES;

INFLUENZA VACCINE;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFLUENZA VACCINATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RISK REDUCTION;

COHORT RESEARCH DATABASE; COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE); IHD (ISCHEMIC HEART DISEASE); INFLUENZA VACCINE; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMPUTER SYSTEMS; DATA COLLECTION; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; SOFTWARE; TAIWAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880047261     PISSN: 01692607     EISSN: 18727565     Source Type: Journal    
DOI: 10.1016/j.cmpb.2013.05.006     Document Type: Article

References (23)

1. Murray C.J.L., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504.
2. Cazzola M., Bettoncelli G., Sessa E., Cricelli C., Biscione G. Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration: International Review of Thoracic Diseases 2010, 80:112-119.
3. De Diego C., Vila-Córcoles A., Ochoa O., Rodriguez-Blanco T., Salsench E., Bejarano F., del Puy Muniain M., Fortin M., Canals M. Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. European Heart Journal 2009, 30:209-216.
4. Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C., Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet (London, England) 2005, 366:1165-1174.
5. Calverley P.M.A., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., Yates J.C., Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. New England Journal of Medicine 2007, 356:775-789.
6. Wang C.S., Wang S.T., Lai C.T., Lin L.J., Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007, 25:1196-1203.
7. Anthonisen N.R., Connett J.E., Kiley J.P., Altose M.D., Bailey W.C., Buist A.S., Conway W.A., Enright P.L., Kanner R.E., O'Hara P. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. Journal of the American Medical Association 1994, 272:1497-1505.
8. Gorse G.J., O'Connor T.Z., Young S.L., Habib M.P., Wittes J., Neuzil K.M., Nichol K.L. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. CHEST Journal 2006, 130:1109-1116.
9. Gurfinkel E.P., de la Fuente R.L., Mendiz O., Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions the FLU vaccination acute coronary syndromes (FLUVACS) study. Circulation 2002, 105:2143-2147.
10. Kiyohara K., Kojimahara N., Sato Y., Yamaguchi N. Changes in COPD mortality rate after amendments to the Preventive Vaccination Law in Japan. European Journal of Public Health 2011, 23:133-139.
11. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine 2003, 348:1322-1332.
12. Smith S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Journal of the American College of Cardiology 2006, 47:2130-2139.
13. Make B., Dutro M.P., Paulose-Ram R., Marton J.P., Mapel D.W. Undertreatment of COPD: a retrospective analysis of US managed care and medicare patients. International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:1.
14. Lu P., Bridges C.B., Euler G.L., Singleton J.A. Influenza vaccination of recommended adult populations, US, 1989-2005. Vaccine 2008, 26:1786-1793.
15. Soriano J.B., Visick G.T., Muellerova H., Payvandi N., Hansell A.L. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. CHEST Journal 2005, 128:2099-2107.
16. Sin D.D., Anthonisen N.R., Soriano J.B., Agusti A. Mortality in COPD: role of comorbidities. European Respiratory Journal 2006, 28:1245-1257.
17. Sin D.D., Man S.F.P. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases?. Circulation 2003, 107:1514-1519.
18. Keitel W.A., Cate T.R., Couch R.B., Huggins L.L., Hess K.R. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997, 15:1114-1122.
19. Warren-Gash C., Smeeth L., Hayward A.C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. The Lancet Infectious Diseases 2009, 9:601-610.
20. Naghavi M., Barlas Z., Siadaty S., Naguib S., Madjid M., Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000, 102:3039-3045.
21. Zielinski J., MacNee W., Wedzicha J., Ambrosino N., Braghiroli A., Dolensky J., Howard P., Gorzelak K., Lahdensuo A., Strom K. Causes of death in patients with COPD and chronic respiratory failure. Archivio Monaldi per le malattie del torace 1997, 52:43.
22. Yawn B., Kaplan A. Co-morbidities in people with COPD: a result of multiple diseases, or multiple manifestations of smoking and reactive inflammation. Primary Care Respiratory Journal 2008, 17:199-205.
23. Mapel D.W., Dutro M.P., Marton J.P., Woodruff K., Make B. Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Services Research 2011, 11:43.